GSK PLC (GSK)
40.90
+0.04
(+0.09%)
USD |
NYSE |
Apr 25, 16:00
40.90
0.00 (0.00%)
After-Hours: 20:00
GSK Price to Book Value: 4.914 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 4.910 |
| April 23, 2024 | 4.955 |
| April 22, 2024 | 4.877 |
| April 19, 2024 | 4.776 |
| April 18, 2024 | 4.719 |
| April 17, 2024 | 4.758 |
| April 16, 2024 | 4.800 |
| April 15, 2024 | 4.866 |
| April 12, 2024 | 4.886 |
| April 11, 2024 | 4.902 |
| April 10, 2024 | 4.889 |
| April 09, 2024 | 4.912 |
| April 08, 2024 | 4.908 |
| April 05, 2024 | 4.949 |
| April 04, 2024 | 4.910 |
| April 03, 2024 | 4.991 |
| April 02, 2024 | 5.021 |
| April 01, 2024 | 5.097 |
| March 28, 2024 | 5.151 |
| March 27, 2024 | 5.166 |
| March 26, 2024 | 5.142 |
| March 25, 2024 | 5.146 |
| March 22, 2024 | 5.089 |
| March 21, 2024 | 5.056 |
| March 20, 2024 | 5.004 |
| Date | Value |
|---|---|
| March 19, 2024 | 5.050 |
| March 18, 2024 | 5.029 |
| March 15, 2024 | 5.035 |
| March 14, 2024 | 5.141 |
| March 13, 2024 | 5.175 |
| March 12, 2024 | 5.164 |
| March 11, 2024 | 5.122 |
| March 08, 2024 | 5.148 |
| March 07, 2024 | 5.201 |
| March 06, 2024 | 5.086 |
| March 05, 2024 | 5.084 |
| March 04, 2024 | 5.065 |
| March 01, 2024 | 5.016 |
| February 29, 2024 | 5.000 |
| February 28, 2024 | 5.052 |
| February 27, 2024 | 5.057 |
| February 26, 2024 | 5.052 |
| February 23, 2024 | 5.038 |
| February 22, 2024 | 5.031 |
| February 21, 2024 | 5.005 |
| February 20, 2024 | 5.014 |
| February 16, 2024 | 5.005 |
| February 15, 2024 | 4.984 |
| February 14, 2024 | 4.988 |
| February 13, 2024 | 4.939 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.935
Minimum
Sep 27 2022
18.84
Maximum
Sep 03 2019
5.922
Average
4.986
Median
Apr 28 2023
Price to Book Value Benchmarks
| AstraZeneca PLC | 5.941 |
| Haleon PLC | 1.813 |
| Novo Nordisk A/S | 35.47 |
| Pfizer Inc | 1.603 |
| Sanofi SA | 1.505 |
Price to Book Value Related Metrics
| PE Ratio | 14.63 |
| PS Ratio | 2.361 |
| Price to Free Cash Flow | 16.19 |
| Price | 40.90 |
| Earnings Yield | 6.83% |
| Market Cap | 83.55B |
| Operating PE Ratio | 9.755 |
| Normalized PE Ratio | 13.37 |